Cargando…

SARS-CoV-2 replicon for high-throughput antiviral screening

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus, which is highly pathogenic and classified as a biosafety level 3 (BSL-3) agent, has greatly threatened global health and efficacious antivirals are urgently needed. The high requirement of facilities to manipulate the live virus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qiu-Yan, Deng, Cheng-Lin, Liu, Jing, Li, Jia-Qi, Zhang, Hong-Qing, Li, Na, Zhang, Ya-Nan, Li, Xiao-Dan, Zhang, Bo, Xu, Yi, Ye, Han-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Microbiology Society 2021
Materias:	Animal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295919/ https://www.ncbi.nlm.nih.gov/pubmed/33956592 http://dx.doi.org/10.1099/jgv.0.001583

Ejemplares similares

Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing
por: He, Xi, et al.
Publicado: (2021)

A new screening system for entry inhibitors based on cell-to-cell transmitted syncytia formation mediated by self-propagating hybrid VEEV-SARS-CoV-2 replicon
por: Li, Na, et al.
Publicado: (2022)

A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles
por: Zhang, Ya-Nan, et al.
Publicado: (2020)

An alphavirus replicon particle delivering prefusion-stabilized spike protein provides potent immunoprotection against SARS-CoV-2 Omicron variant
por: Zhang, Hong-Qing, et al.
Publicado: (2022)

Development of A MERS-CoV Replicon Cell Line for Antiviral Screening
por: Chen, Jing, et al.
Publicado: (2021)

Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors
por: Luo, Yuewen, et al.
Publicado: (2021)

Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle
por: Kamrud, K. I., et al.
Publicado: (2010)

Inhibition of the foot-and-mouth disease virus subgenomic replicon by RNA aptamers
por: Forrest, Sophie, et al.
Publicado: (2014)

Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening
por: Tanaka, Tomohisa, et al.
Publicado: (2022)

High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery
por: Ge, Feng, et al.
Publicado: (2008)

A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2
por: Zhang, Zhe-Rui, et al.
Publicado: (2020)

Berbamine hydrochloride potently inhibits SARS-CoV-2 infection by blocking S protein-mediated membrane fusion
por: Zhang, Zhe-Rui, et al.
Publicado: (2022)

A high throughput antiviral screening platform for alphaviruses based on Semliki Forest virus expressing eGFP reporter gene
por: Shi, Yu-Jia, et al.
Publicado: (2023)

A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation
por: Kotaki, Tomohiro, et al.
Publicado: (2021)

Generation and characterization of Japanese encephalitis virus expressing GFP reporter gene for high throughput drug screening
por: Zhang, Zhe-Rui, et al.
Publicado: (2020)

A novel rabies vaccine based on infectious propagating particles derived from hybrid VEEV-Rabies replicon
por: Zhang, Ya-Nan, et al.
Publicado: (2020)

Construction of a dengue virus type 4 reporter replicon and analysis of temperature-sensitive mutations in non-structural proteins 3 and 5
por: Alcaraz-Estrada, Sofia L., et al.
Publicado: (2010)

Increased morbidity of obese mice infected with mouse-adapted SARS-CoV-2
por: Zhang, Ya-Nan, et al.
Publicado: (2021)

Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice
por: Li, Jia-Qi, et al.
Publicado: (2021)

Construction of Fosmid-based SARS-CoV-2 replicons for antiviral drug screening and replication analyses in biosafety level 2 facilities
por: Takazawa, Shunta, et al.
Publicado: (2023)

Different pathogenesis of SARS-CoV-2 Omicron variant in wild-type laboratory mice and hamsters
por: Zhang, Ya-Nan, et al.
Publicado: (2022)

Construction of a Noninfectious SARS-CoV-2 Replicon for Antiviral-Drug Testing and Gene Function Studies
por: Nguyen, Hai Trong, et al.
Publicado: (2021)

Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir
por: Pohl, Marie O., et al.
Publicado: (2021)

Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation
por: Wang, Bei, et al.
Publicado: (2021)

A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery
por: Jin, Yun-Yun, et al.
Publicado: (2021)

Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom
por: Chappell, Joseph G., et al.
Publicado: (2021)

A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2
por: Zhang, Yang, et al.
Publicado: (2021)

Replication and single-cycle delivery of SARS-CoV-2 replicons
por: Ricardo-Lax, Inna, et al.
Publicado: (2021)

SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening
por: Vanhulle, Emiel, et al.
Publicado: (2022)

Evolutionary Trajectory of the Replication Mode of Bacterial Replicons
por: Xie, Bin-Bin, et al.
Publicado: (2021)

Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture
por: Zhang, Ya-Nan, et al.
Publicado: (2020)

A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis
por: Feng, Xiaolong, et al.
Publicado: (2022)

Epidemiology and genetic characteristics of murine kobuvirus from faecal samples of Rattus losea, Rattus tanezumi and Rattus norvegicus in southern China
por: Zhang, Minyi, et al.
Publicado: (2021)

Development of a Novel Chikungunya Virus-Like Replicon Particle for Rapid Quantification and Screening of Neutralizing Antibodies and Antivirals
por: Lin, Hui-Chung, et al.
Publicado: (2023)

Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes
por: Davies, Katherine, et al.
Publicado: (2021)

Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2
por: Li, Shi-Hua, et al.
Publicado: (2013)

Establishment of a Replicon Reporter of the Emerging Tick-Borne Bourbon Virus and Use It for Evaluation of Antivirals
por: Hao, Siyuan, et al.
Publicado: (2020)

The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection
por: Henss, Lisa, et al.
Publicado: (2021)

ARF6 is a host factor for SARS-CoV-2 infection in vitro
por: Mirabelli, C., et al.
Publicado: (2023)

High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors
por: Zang, Yi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cb9mt08c2pbf307487rb02d1to